• HIV-1 Cell–Cell Signalling Remodels Nuclear Pores to Enable

  2026-06-04

  The reference study uncovers how HIV-1 exploits cell–cell contact to trigger nuclear pore complex (NPC) remodelling and license infection of otherwise resistant resting CD4+ T cells. By mapping the underlying CD4–LCK–CDK1 signalling cascade during cell–cell spread, the research redefines our understanding of viral entry barriers and T cell permissivity.

• Halazone and Oxidant Effects on Sodium Channel Inactivation

  2026-06-04

  This article analyzes how halazone and related oxidants impact sodium current inactivation in voltage-clamped frog nerve fibers, as reported by Rack et al. The study reveals that halazone modifies inactivation kinetics, likely through lipid membrane interactions, with implications for both neurophysiological research and the application of antimicrobial sulfonamide derivatives.

• SAR405 as a Vps34 Inhibitor: Optimizing Autophagy Assays

  2026-06-03

  SAR405 delivers unmatched precision in autophagy inhibition through selective Vps34 targeting, enabling researchers to dissect vesicle trafficking and lysosome function with nanomolar sensitivity. This guide offers actionable workflows, troubleshooting insights, and a translational bridge to the latest energy-stress research.

• Anagliptin (SK-0403): Advanced Workflows for Vascular Resear

  2026-06-03

  Anagliptin (SK-0403) enables precise dissection of DPP-4 inhibition and vasorelaxant mechanisms, uniquely bridging diabetes and cardiovascular research workflows. Discover how to optimize vascular smooth muscle assays and troubleshoot key variables for reproducible, high-impact metabolic and vascular studies.

• Glabridin-Gold(I) Complex 6d Enhances Antitumor Immunity via

  2026-06-02

  The reference paper presents a novel glabridin-gold(I) complex (6d) that synergistically targets thioredoxin reductase and MAPK pathways to modulate the tumor immune microenvironment in liver cancer. This dual-action approach enhances dendritic cell maturation, reduces immunosuppressive cells, and suppresses PD-L1, offering a promising strategy for combination immunotherapy.

• Sulfo-Cy3 Azide: Precision Bioconjugation Reagent for Click

  2026-06-02

  Sulfo-Cy3 azide sets a new standard for high-sensitivity Click Chemistry fluorescent labeling in aqueous systems, outperforming traditional dyes in brightness, solubility, and reduction of fluorescence quenching. Its hydrophilic design empowers robust workflows for labeling alkyne-modified oligonucleotides and intact cells, enabling reproducible imaging in neurodevelopmental and proteomics research.

• CHIR 99021 Trihydrochloride: Engineering Organoid Fate

  2026-06-01

  Explore how CHIR 99021 trihydrochloride, a potent GSK-3 inhibitor, enables a step-change in translational organoid research by facilitating controlled, reversible modulation of stem cell self-renewal and differentiation. This article bridges mechanistic insight, protocol guidance, and future-facing strategy for researchers aiming to build scalable, physiologically relevant models for disease and regenerative medicine.

• Exercise Limitation Precedes Muscle Dysfunction in PH Rat Mo

  2026-06-01

  This study clarifies that reduced exercise capacity in pulmonary hypertension (PH) rat models develops before intrinsic skeletal muscle dysfunction. The findings suggest central cardiopulmonary impairment, rather than muscle mitochondrial or structural defects, is the primary early driver of exercise intolerance in experimental PH, which has implications for both disease modeling and intervention timing.

• Patient-Derived Gastric Cancer Assembloids for Drug Response

  2026-05-31

  This study introduces an advanced patient-derived gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations. By more accurately recapitulating the complex tumor microenvironment, the model reveals critical influences of stromal components on gene expression and drug sensitivity, supporting improved personalized therapy research.

• Thymoquinone: Applied Workflows for Cardioprotection Researc

  2026-05-30

  Thymoquinone, or 2-isopropyl-5-methylcyclohexa-2,5-diene-1,4-dione, delivers precise modulation of oxidative and iron-mediated cardiac injury, making it indispensable for dissecting doxorubicin-induced cardiotoxicity in translational workflows. This guide details protocol design, mechanistic advantages, and troubleshooting strategies to maximize research value with APExBIO's thymoquinone.

• AP20187 (SKU B1274): Reliable Conditional Gene Expression To

  2026-05-29

  This article addresses key laboratory challenges in cell viability and signaling assays, focusing on AP20187 (SKU B1274) as a data-backed chemical inducer of dimerization. Drawing on quantitative evidence and recent mechanistic studies, we evaluate AP20187’s protocol optimization, interpretative robustness, and vendor reliability. Researchers will gain practical guidance for achieving reproducible, sensitive, and safe workflows with this validated reagent.

• LG 101506: Applied RXR Modulator Workflows & Troubleshooting

  2026-05-29

  LG 101506 empowers researchers to interrogate RXR signaling with precision, enabling advanced study of nuclear receptor biology and immune checkpoint regulation. This guide translates frontline findings and best practices into actionable workflows, troubleshooting, and protocol enhancements for maximizing the impact of this RXR modulator.

• Drug-Sensitized Yeast Platform Uncovers TOR Inhibitors with

  2026-05-28

  This study introduces a drug-sensitized yeast system that dramatically enhances the detection of TOR inhibitors, enabling rapid and cost-effective screening for compounds with potential geroprotective and anti-cancer properties. Notably, canagliflozin was tested and found not to inhibit TOR, clarifying its mechanistic specificity for researchers.

• WY-14643 (Pirinixic Acid): Optimizing PPARα-Driven Metabolic

  2026-05-28

  WY-14643 (Pirinixic Acid) elevates metabolic and inflammatory research through potent, selective PPARα activation and robust in vivo efficacy. This guide details advanced workflows, protocol nuances, and troubleshooting strategies—empowering researchers to unlock precision in metabolic disorder models and liver regeneration assays.

• Liproxstatin-1: Optimizing Ferroptosis Inhibition in Researc

  2026-05-27

  Liproxstatin-1 stands out as a nanomolar potent ferroptosis inhibitor, revolutionizing studies of iron-dependent cell death across renal, neurodegenerative, and sex-specific organ injury models. This guide unpacks best-practice protocols, advanced troubleshooting, and unique applications, leveraging both landmark literature and real-world assay insights.

16024 records 1/1069 page Next 12345 下5页 Last page